Literature DB >> 17189117

Minimally invasive parathyroidectomy using the lateral focused miniincision approach: Is there a learning curve for surgeons experienced in the open procedure?

Patsy S H Soon1, Michael W Yeh, Mark S Sywak, Paul Roach, Leigh W Delbridge, Stan B Sidhu.   

Abstract

BACKGROUND: Minimally invasive parathyroidectomy (MIP) has gained acceptance as the standard of care for management of primary hyperparathyroidism in which a single adenoma can be localized. The aim of this study was to determine if there is a learning curve for MIP using the lateral focused miniincision approach performed by surgeons experienced in open parathyroidectomy. STUDY
DESIGN: This is a retrospective case series comprising all parathyroid operations undertaken by three surgeons in the University of Sydney Endocrine Surgical Unit from 2003 to 2005. Outcomes of the experienced surgeon were compared with those of the two surgeons commencing practice.
RESULTS: There were 699 parathyroidectomies performed in the Unit during the 36-month period (experienced surgeons: 438 versus commencing physicians: 261). Of the parathyroidectomies performed, 57% done by experienced surgeons were minimally invasive compared with 38% of those performed by surgeons commencing practice (p < 0.001). There were no differences in the number of complications (p = 0.21), conversions to open exploration (p = 0.6), and cure rates (p = 0.9) in the MIP patients in both groups. The initial (first 131 patients) and subsequent (next 130 patients) parathyroidectomy experiences of surgeons commencing practice were examined. In the initial experiences, 28% of the cases were minimally invasive compared with 48% in the subsequent experiences (p < 0.001). There were no differences in the number of complications (p = 0.3), conversions to open exploration (p = 0.9), and cure rates (p = 0.9).
CONCLUSIONS: For surgeons experienced in open parathyroidectomy, there is no technical learning curve using the lateral focused miniincision technique for MIP. There is, however, a learning curve for patient selection.

Entities:  

Mesh:

Year:  2007        PMID: 17189117     DOI: 10.1016/j.jamcollsurg.2006.10.017

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Intraoperative real-time (99m)Tc-sestamibi scintigraphy with miniature gamma camera allows minimally invasive parathyroidectomy without ioPTH determination in primary hyperparathyroidism.

Authors:  Norberto Cassinello; Joaquin Ortega; Salvador Lledo
Journal:  Langenbecks Arch Surg       Date:  2009-06-27       Impact factor: 3.445

2.  Bilateral internal jugular venous sampling for parathyroid hormone determination in patients with nonlocalizing primary hyperparathyroidism.

Authors:  Raul Alvarado; Goswin Meyer-Rochow; Mark Sywak; Leigh Delbridge; Stan Sidhu
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

3.  Surgeon performed ultrasound facilitates minimally invasive parathyroidectomy by the focused lateral mini-incision approach.

Authors:  Patsy S H Soon; Leigh W Delbridge; Mark S Sywak; Beverley M Barraclough; Pam Edhouse; Stan B Sidhu
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 4.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

5.  Minimally invasive parathyroidectomy.

Authors:  Lee F Starker; Annabelle L Fonseca; Tobias Carling; Robert Udelsman
Journal:  Int J Endocrinol       Date:  2011-05-23       Impact factor: 3.257

6.  A comparison of minimally invasive video-assisted parathyroidectomy and traditional parathyroidectomy for parathyroid adenoma.

Authors:  Paolo Del Rio; Diego Vicente; Umberto Maestroni; Anna Totaro; Gian Maria Casoni Pattacini; Itzhak Avital; Alexander Stojadinovic; Mario Sianesi
Journal:  J Cancer       Date:  2013-07-03       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.